| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Former Shockwave Medical CEO joins Solenic Medical's board | ||
| Fr | Anaconda Biomed brings in $56 million | ||
| Fr | Precision Neuroscience raises $250M in Series D for its BCI | ||
| Fr | Fresenius discontinuing Chinese sales of 4008A hemodialysis system | ||
| Do | Perfuze's super-bore stroke catheter tops conventional, cyclic aspiration in bench study | ||
| Do | Edwards Lifesciences taps GE HealthCare vet to head new digital engineering group | ||
| Mi | Abbott partners with Berry Street to add nutrition coaching to Lingo | ||
| Mi | Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring | ||
| Mi | GE HealthCare taps retiring AT&T CFO for board of directors | ||
| Mi | Boston Scientific MedSurg, Asia Pacific leader Art Butcher to retire | ||
| Mi | DePuy Synthes launches next-generation automated fracture fixation system | ||
| Di | FDA clears at-home dental dressing for non-surgical periodontal procedures | ||
| Di | CVRx taps new CFO from Nyxoah | ||
| Di | BD brings on new chief information and digital officer from Lenovo | ||
| Mo | Cooper Companies continues to see activist pressure to sell divisions, replace CEO | ||
| Mo | Cordis earns FDA nod for Selution SLR drug-eluting balloon | ||
| Mo | Siemens Healthineers links with Novo to advance liver fibrosis blood test | ||
| Mo | GE HealthCare rolls out AI software for predicting care bottlenecks | ||
| Mo | Wandercraft's self-balancing Eve exoskeleton begins US launch | ||
| 18.09. | Autonomix taps former Medtronic FDA counsel head for board of directors | ||
| 18.09. | Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure | ||
| 18.09. | Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say | ||
| 17.09. | Science Corp. names president as it looks to roll out vision-restoring implant | ||
| 17.09. | Mindray looks to fill hospital ventilator gap left by Philips' exit | ||
| 17.09. | Johnson & Johnson drops LAA assets following suspended pivotal study |